Jazz Pharmaceuticals plc buy JPMorgan Chase & Co.
Start price
25.03.24
/
50%
€112.05
Target price
25.03.25
€175.31
Performance (%)
-8.75%
Price
03.05.24
€102.25
Summary
This prediction is currently active. With a performance of -8.75%, the BUY prediction for Jazz Pharmaceuticals plc by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 25.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.049% | -0.049% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at JPMorgan Chase & Co. from $170.00 to $190.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.35
29.02.24
29.02.24
€157.28
28.02.25
28.02.25
-6.49%
03.05.24
03.05.24
